NeuroSense Therapeutics Ltd.
NRSN35
$1.51arrow_drop_up3.76%$0.05
Penny Stock
NRSN35
$1.51
arrow_drop_up3.76%Performance History
There's no data available for key stats
There's no data available for ratios/profitability stats
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
NeuroSense Therapeutics Ltd. (NRSN)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Alon Ben-Noon
- Headquarters
- Herzliya
- Employees
- 14
- Exchange
- NASDAQ
Keep an eye on NeuroSense Therapeutics Ltd.
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.